Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD, Author at Infectious Disease Advisor

feature

Biotherapeutics for the Prevention of Clostridium difficile Infection

Experts review biotherapeutics for the prevention of C difficile infection, including probiotics, fecal microbiota transplantation, and nontoxigenic C difficile.

By

Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD

August 16, 2017

feature

C difficile Treatment and Prevention: Novel Antibiotics and Immunologic Therapies

Experts review novel antibiotic therapies that may limit the impact on the gut microbiome, as well as passive immunization products that may bolster the immune response to C difficile toxins and possibly reduce the frequency of toxigenic strains.

By

Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD

June 8, 2017

feature

Review of Clostridium difficile Vaccines in Development

Drs Kociolek and Shulman, from the division of infectious diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago in Illinois, review all the current vaccine candidates in development for Clostridium difficile infection.

By

Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD

March 24, 2017

Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD

All articles by Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD